Prognostic Impact of Claudin18.2 and TROP2 Expression in Advanced Gastric Cancer Treated With Nivolumab. Awatsu T, Kadono T, Shoji H, Hirose T, et al. Anticancer Res 2026;46:1021-1035.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Awatsu T, Kadono T, Shoji H, Hirose T, et al. Prognostic Impact of Claudin18.2 and TROP2 Expression in Advanced Gastric Cancer Treated With Nivolumab. Anticancer Res 2026;46:1021-1035.
PMID: 41617423